"Nanobiopsy" allows scientists to operate on living cells

By By Sam Wong | 27 Dec 2013

1

Scientists have developed a device that can take a "biopsy" of a living cell, sampling minute volumes of its contents without killing it.

 
The technique uses a nanopipette to suck out minute volumes of a cell's contents.  

Much research on molecular biology is carried out on populations of cells, giving an average result that ignores the fact that every cell is different. Techniques for studying single cells usually destroy them, making it impossible to look at changes over time.

The new tool, called a nanobiopsy, uses a robotic glass nanopipette to pierce the cell membrane and extract a volume of around 50 femtolitres – 0.00000000000005 litres, around one per cent of the cell's contents.

It will allow scientists to take samples repeatedly, to study the progression of disease at a molecular level in an individual cell. It can also be used to deliver material into cells, opening up ways to reprogram diseased cells.

''This is like doing surgery on individual cells,'' said Dr Paolo Actis, from the Department of Medicine at Imperial College London, who developed the technology with colleagues at the University of California, Santa Cruz.

''This technology will be extremely useful for research in many areas. You could use it to dynamically study how cancer cells are different from healthy cells, or look at how brain cells are affected by Alzheimer's disease. The possibilities are immense.''

To get inside the cell, the nanopipette is plunged downwards about one micrometre to pierce the cell membrane. Applying a voltage across the tip makes fluid flow into the pipette. When the pipette is removed from the cell, the membrane remains intact and the cell retains its shape.

The device is based on a scanning ion conductance microscope, which uses a robotic nanopipette, about 100 nanometres in diameter, to scan the surface of cells. The nanopipette is filled with an electrolyte solution and the ion current is measured inside the tip. When the pipette gets close to a cell membrane, the ion current decreases.

This measurement is used to guide the tip across the surface of a sample at a constant distance, producing a picture of the surface.

In an initial study published in the journal ACS Nano, the researchers used the nanobiopsy technique to extract and sequence messenger RNA, molecules carrying genetic code transcribed from DNA in the cell's nucleus. This allowed them to see which genes were being expressed in the cell.

They were also able to extract whole mitochondria – the power units of the cell. Mitochondria contain their own DNA, and the researchers discovered that the genomes of different mitochondria in the same cell are different.

They are now working on adapting the technology to incorporate sensors on the pipette tip that can instantly measure different molecules.

The research was funded by the US National Cancer Institute and National Institutes of Health.

Latest articles

Global Chip Sales Expected to Hit $1 Trillion This Year, Industry Group Says

Global Chip Sales Expected to Hit $1 Trillion This Year, Industry Group Says

Citi to Match Government Seed Funding for Children’s ‘Trump Accounts’

Citi to Match Government Seed Funding for Children’s ‘Trump Accounts’

Huawei-Backed Aito Partners With UAE Dealer to Enter Middle East Market

Huawei-Backed Aito Partners With UAE Dealer to Enter Middle East Market

AI is No Bubble: Nvidia Supplier Wistron Sees Order Surge Through 2027

AI is No Bubble: Nvidia Supplier Wistron Sees Order Surge Through 2027

Tech Selloff Weighs on Asian Markets; Indonesia Slides After Moody’s Outlook Cut

Tech Selloff Weighs on Asian Markets; Indonesia Slides After Moody’s Outlook Cut

Amazon Plans $200 Billion AI Spending Surge; Shares Slide on Investor Jitters

Amazon Plans $200 Billion AI Spending Surge; Shares Slide on Investor Jitters

Server CPU Shortages Grip China as AI Boom Strains Intel and AMD Supply Chains

Server CPU Shortages Grip China as AI Boom Strains Intel and AMD Supply Chains

OpenAI launches ‘Frontier’ AI agent platform in enterprise push

OpenAI launches ‘Frontier’ AI agent platform in enterprise push

Toyota set for third straight quarterly profit drop as costs and tariffs weigh

Toyota set for third straight quarterly profit drop as costs and tariffs weigh